Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23415)

• Formulation Name: Cysteamine Bitartrate eq 75mg base capsule
• Company: Horizon Therapeutics Usa

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Cysteamine	(DMSYFM8)	Nephropathic cystinosis	5C60	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Gelatin	(E00630)	Not Available	Other agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent